Navigation Links
McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy
Date:7/8/2008

NEW YORK, July 8 /PRNewswire/ -- McGraw-Hill Professional, a leading global provider of information resources for the scientific and medical communities, today announced the addition of a robust new drug effectiveness reference to its comprehensive online pharmacy education resource, AccessPharmacy (http://www.accesspharmacy.com). Through an alliance with Doctor Evidence, developer of distributed databases generated from clinical studies, AccessPharmacy now provides in-context access to drug efficacy data via effectiveness statements, generated from actual clinical endpoints in published clinical studies, for over 500 common diseases and the 300 most commonly prescribed medications.

Seamlessly integrated into AccessPharmacy's intuitive interface, the Doctor Evidence statements translate rigorous meta-analyses of published clinical studies into clear, actionable statements. Users simply search for a brand name or generic drug topic, select an associated outcome or adverse effect, and view a straightforward sentence summarizing the available evidence. The statements are also organized according to disease, giving users the ability to start from a list of the most common medications prescribed for a given condition and then narrow down to outcomes or adverse effects. In all cases, effectiveness statements include links to the associated studies and abstracts. The effectiveness statements supplement the integrated drug database already available on AccessPharmacy.

"In light of the increasing focus on patient care for pharmacists and pharmacy educators, drug effectiveness statements provide a crucial new tool for reaching evidence-based recommendations," says Scott Grillo, medical publisher, McGraw-Hill Professional. "By making this data available on AccessPharmacy, we combine the best in educational resources through titles such as "Pharmacotherapy: A Pathophysiologic Approach" with actionable knowledge regarding efficacy."

Doctor Evidence regularly updates its efficacy oriented Drug Awareness Database ("DAD") of over 2,600 randomized controlled trials and 7,500 unique clinical outcomes to ensure access to the most critical and current data. Physicians with expertise in evidence-based medicine, medical librarians, and information technology experts oversee the meta-analysis algorithms and routines that generate the effectiveness statements to ensure validity.

About AccessPharmacy

Launched in April 2007, AccessPharmacy is an online curricular resource designed to meet the changing demands of pharmacy education. A flexible resource, AccessPharmacy allows students to select a core curriculum topic, browse by organ system, review textbooks, or search across leading pharmacy references online. AccessPharmacy also offers integrated case studies, care plans, virtual cases, molecular-level animations, functional calculators, and interactive NAPLEX review. More information on this and other products can be found on http://www.accesspharmacy.com.

About McGraw-Hill Professional

McGraw-Hill Professional is a unit of McGraw-Hill Education, a leading global provider of instructional, assessment and reference solutions that empower professionals and students of all ages. McGraw-Hill Education, a division of The McGraw-Hill Companies (NYSE: MHP), has offices in 33 countries and publishes in more than 40 languages. Additional information is available at http://www.mheducation.com.


'/>"/>
SOURCE McGraw-Hill Education
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
2. Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO08
3. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
4. BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
5. The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week (April 19-26)
6. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
7. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
8. Focus Diagnostics Launches Laboratory Test for Chikungunya Virus
9. deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes
10. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
11. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 ... ... Company, Cal Dining at the University of California Berkeley, and other leading institutions ... leverages the buying power of institutions to change the way animals are raised ...
Breaking Medicine News(10 mins):